
Commit Biologics raises $60M seed to take COM002 to the clinic
The Copenhagen biotech closed a $60M (€54M) seed backed by AbbVie Ventures, M Ventures and Ackermans & van Haaren to push complement-powered immune engagers for lymphoma and autoimmune disease.








































































































































































































































































































































